Wellness, Actually with Emily Oster & Perry Wilson, MD cover image

Ozempic 101: A doctor explains the data and science behind weight-loss drugs

Wellness, Actually with Emily Oster & Perry Wilson, MD

00:00

Exploring GLP1 Agonists and Their Role in Weight Loss and Diabetes Treatment

The chapter delves into the responsibilities of endocrinologists in addressing hormone-related conditions, particularly diabetes and weight issues, by examining GLP1 agonist drugs like Ozempic and Wigovi. It compares the evolution of these medications from diabetes treatment to weight loss aids, emphasizing their mechanisms of action on insulin regulation and sugar metabolism.

Play episode from 03:32
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app